AllianzIM U.S. Equity Buffer20 Nov ETF (BATS:NVBW – Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 30th, there was short interest totaling 4,961 shares, an increase of 4,329.5% from the October 15th total of 112 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily volume of 22,693 shares, the days-to-cover ratio is currently 0.2 days.
AllianzIM U.S. Equity Buffer20 Nov ETF Stock Performance
NVBW opened at $36.79 on Wednesday. The business’s fifty day moving average is $36.67 and its two-hundred day moving average is $35.34. The company has a market cap of $106.69 million, a price-to-earnings ratio of 24.91 and a beta of 0.40. AllianzIM U.S. Equity Buffer20 Nov ETF has a one year low of $32.83 and a one year high of $37.24.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in NVBW. Harbour Investments Inc. purchased a new stake in shares of AllianzIM U.S. Equity Buffer20 Nov ETF in the 3rd quarter worth about $1,088,000. Farther Finance Advisors LLC grew its stake in AllianzIM U.S. Equity Buffer20 Nov ETF by 1.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 18,187 shares of the company’s stock valued at $664,000 after acquiring an additional 301 shares during the last quarter. Finally, Blue Bell Private Wealth Management LLC purchased a new position in AllianzIM U.S. Equity Buffer20 Nov ETF during the 3rd quarter valued at about $73,000.
About AllianzIM U.S. Equity Buffer20 Nov ETF
The Allianzim U.S. Large Cap Buffer20 Nov ETF (NVBW) is an exchange-traded fund that is based on the S&P 500 index. The fund aims for specific buffered losses and capped gains on the S&P 500 over a specific holdings period. The actively-managed fund holds options and collateral. NVBW was launched on Oct 31, 2022 and is managed by Allianz.
Featured Stories
- Five stocks we like better than AllianzIM U.S. Equity Buffer20 Nov ETF
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
Receive News & Ratings for AllianzIM U.S. Equity Buffer20 Nov ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AllianzIM U.S. Equity Buffer20 Nov ETF and related companies with MarketBeat.com's FREE daily email newsletter.
